Chemical Structure (Xolremdi 01)
Xolremdi Capsule, Gelatin Coated
Product Images NDC 83296-100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xolremdi (NDC 83296-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by X4 Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Xolremdi 02)
This is a table displaying the time (in hours) for different groups labeled as "XOLREMDI" and "Placebo" at various weeks (0, 13, 26, 39, and 52). The numbers in the table are likely measurements or results for each group at the respective weeks.*
Principal Display Panel (100 mg Capsule Bottle Label)
This text provides information about Mavorixafor capsules with a dosage of 100 mg. It advises swallowing the capsules whole and not opening, breaking, or chewing them. The capsules should be stored at a cool temperature, and the bottle should be kept closed. The recommended dosage should be determined by a healthcare professional. For more details or in case of any questions, contact X4 Pharmaceuticals in Boston, MA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
